Q4 2024 Earnings Call Transcript March 27, 2025 Innate Pharma S.A. misses on earnings expectations. Reported EPS is $-0.33474 ...

Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...

A new study from Cornell University has strengthened the case for using a specific group of molecules—known as microRNAs—as ...

A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop resistance to therapy. Researchers at Baylor College of Medicine showed ...

Immatics' lead asset, IMA203, shows promising early data with a 57% ORR in heavily pretreated patients, but toxicity concerns ...

A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or ...

Favorable initial results from a phase 1/2 trial of solnerstotug in PD-L1–resistant tumors showed a 14% response rate and 62% ...

We recently published a list of 15 Cheapest Stocks Insiders Are Buying In March. In this article, we are going to take a look ...

Negative surgical margins regardless of surgery type was associated with increased overall survival in patients with Merkel cell carcinoma.

Preliminary efficacy data from Phase 1/2 dose expansion cohort show durable responses and tumor shrinkage in a PD-(L)1 resistant “hot” tumor ...

A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop ...